Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5

+ Free Shipping
Guaranteed Safe Checkout

Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5

Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5

Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5

Ifoxetine (CGP-15,210-G) is a selective serotonin reuptake inhibitor (SSRI) which was investigated as an antidepressant in the 1980s but was never marketed.[1][2][3] Ifoxetine selectively blocks the reuptake of serotonin in the brain supposedly without affecting it in the periphery.[3] Supporting this claim, ifoxetine was found to be efficacious in clinical trials and was very well tolerated, producing almost no physical side effects or other complaints of significant concern.[3]

References

  1.  Burrows GD, McIntyre IM, Judd FK, Norman TR (August 1988). “Clinical effects of serotonin reuptake inhibitors in the treatment of depressive illness”. The Journal of Clinical Psychiatry. 49 Suppl: 18–22. PMID 3045107.
  2.  Waldmeier PC, Maître L, Baumann PA, et al. (October 1986). “Ifoxetine, a compound with atypical effects on serotonin uptake”. European Journal of Pharmacology. 130 (1–2): 1–10. doi:10.1016/0014-2999(86)90177-9. PMID 2877890.
  3.  Delini-Stula A, Fischbach R, Gauthier JM, et al. (July 1987). “First clinical experience with ifoxetine, a new 5-HT reuptake blocker with particular emphasis on the side-effect profile of the 5-HT-uptake inhibiting drugs”. International Clinical Psychopharmacology. 2 (3): 201–15. doi:10.1097/00004850-198707000-00003. PMID 3320185.
Ifoxetine (CGP 15210G) is a 5-HT reuptake inhibitor. Ifoxetine specifically and selectively blocks the reuptake of 5-HT in the brain without affecting peripheral (platelet) 5-HT uptake. Ifoxetine inhibits the uptake of radiolabeled 5-HT by rat brain synaptosomes both in vitro and in vivo. Ifoxetine also has antidepressant effects.
Biological Activity I Assay Protocols (From Reference)

Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5

Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5

Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5

Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5

Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5

Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5

Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5

Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5

Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5

Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5

Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C13H19NO2
Molecular Weight
221.30
Exact Mass
221.142
CAS #
66208-11-5
Related CAS #
Ifoxetine hemisulfate
PubChem CID
71971
Appearance
Typically exists as solids at room temperature
Hydrogen Bond Donor Count
2
Rotatable Bond Count
2
Heavy Atom Count
16
Complexity
222
Defined Atom Stereocenter Count
2
SMILES
CC1=C(C(=CC=C1)O[C@H]2CCNC[C@H]2O)C
InChi Key
ZHFIAFNZGWCLHU-YPMHNXCESA-N
InChi Code
InChI=1S/C13H19NO2/c1-9-4-3-5-12(10(9)2)16-13-6-7-14-8-11(13)15/h3-5,11,13-15H,6-8H2,1-2H3/t11-,13+/m1/s1
Chemical Name
(3R,4S)-4-(2,3-dimethylphenoxy)piperidin-3-ol
Synonyms
CGP-15210G
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

4°C     2 years

In solvent   -80°C    6 months

-20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
Solubility (In Vivo)
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.


Injection Formulations
(e.g. IP/IV/IM/SC)

Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).

View More

Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)


Oral Formulations

Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).

View More

Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders


 

Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.


 (Please use freshly prepared in vivo formulations for optimal results.)

Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 4.5188 mL 22.5938 mL 45.1875 mL
5 mM 0.9038 mL 4.5188 mL 9.0375 mL
10 mM 0.4519 mL 2.2594 mL 4.5188 mL
  1. Ifoxetine

    (Synonyms: CGP-15210G)

    Ifoxetine (CGP 15210G) is an inhibitor of 5-HT reuptake. Ifoxetine specifically and selectively blocks the 5-HT reuptake in the brain without affecting the 5-HT uptake processes in the periphery (blood platelets). Ifoxetine inhibits the uptake of radiolabelled 5-HT into rat brain synaptosomes in vitro or ex vivo. Ifoxetine has antidepressant properties.

    For research use only. We do not sell to patients.

    • CAS No.:66208-11-5
    • Formula:C13H19NO2
    • Molecular Weight:221.30
    • Storage:

      Please store the product under the recommended conditions in the Certificate of Analysis.

    Ifoxetine (CGP-15210G) | 5-HT reuptake inhibitors | CAS 66208-11-5 …

    Ifoxetine (CGP 15210G) is a 5-HT reuptake inhibitor. Ifoxetine specifically and selectively blocks the reuptake of 5-HT in the brain …

    Ifoxetine (CGP-15210G) | 5-HT Reuptake Inhibitor | MedChemExpress

    Ifoxetine (CGP 15210G) is an inhibitor of 5-HT reuptake. Ifoxetine specifically and selectively blocks the 5-HT reuptake in the brain …

    Ifoxetine Chemical Structure
  2. Ifoxetine | 5-HT Reuptake Inhibitor | 66208-11-5 | AdooQ®

    Ifoxetine is a selective inhibitor of the serotonin (5-HT) reuptake process, primarily targeting the central nervous system while sparing …

  3. Ifoxetine 66208-11-5 | MedChemExpress

    MedChemExpress provides Ifoxetine CAS 66208-11-5, related Reference Standards, Isotope-Labeled or GMP Grade Compounds, …

  4. 66208-11-5 | Ifoxetine | ChemScene

    ChemScene Provide CAS 66208-11-5, Ifoxetine, CGP-15210G, Formula:C13H19NO2, MW:221.3000. We also provide services …

    Ifoxetine | 66208-11-5 – ChemicalBook

    Ifoxetine (CAS 66208-11-5) information, including chemical properties, structure, melting point, boiling point, density, formula, …

  5. Ifoxetine | CAS# 66208-11-5 | Biochemical | MedKoo

    Description: WARNING: This product is for research use only, not for human or veterinary use. Ifoxetine is a 5-HT reuptake inhibitor.

  6. Ifoxetine – Immunomart

    Web ID – T68910 Storage Temperature – -20℃ Shipping – Blue Ice Molecular Formula – C13H19NO2 CAS Number – 66208-11-5 …

  7. Ifoxetine – HY-108973A Hycultec GmbH

    Ifoxetine (CGP 15210G) is an inhibitor of 5-HT reuptake. Ifoxetine specifically and selectively blocks the 5-HT reuptake in the brain …

  8. Ifoxetine CAS # 66208-11-5 – tradingchem.com

    Ifoxetine (66208-11-5) CAS Registry Number: 66208-11-5 Synonyms: Ifoxetine;Ifoxetinum;Ifoxetina [INN-Spanish];3S,4R-4- (2,3 …

Reviews

There are no reviews yet.

Be the first to review “Buy Ifoxetine (CGP-15-210-G) Cas 66208-11-5”

Your email address will not be published. Required fields are marked *

Shopping Cart